These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8849921)

  • 1. An evaluation of the contribution of the Swedish International Development Authority (SIDA) to leprosy control in India based on the implementation of multiple drug therapy (MDT) 1981-1993.
    Peat M; Brolin L; Ganapati R; McDougall AC; Revankar CR; Watson JW
    Indian J Lepr; 1995; 67(4):447-65. PubMed ID: 8849921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in new case-detection leprosy in Bihar, India.
    Vijayakumaran P; Prasad B; Krishnamurthy P
    Indian J Lepr; 2006; 78(2):145-51. PubMed ID: 16927849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global strategy for further reducing the leprosy burden and sustaining leprosy control activities 2006-2010. Operational guidelines.
    World Health Organization Regional Office for South-East Asia New Delhi
    Lepr Rev; 2006 Sep; 77(3):IX, X, 1-50. PubMed ID: 17172004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The national leprosy eradication programme in India.
    Mittal BN
    World Health Stat Q; 1991; 44(1):23-9. PubMed ID: 2068822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on integration of the National Leprosy Eradication Programme into primary health care services: a pilot project.
    Parkash I; Rao PS
    Indian J Lepr; 2003; 75(1):25-35. PubMed ID: 15253392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in detection of new leprosy cases at two centres in Himachal Pradesh, India: a ten-year study.
    Mahajan VK; Sharma NL; Rana P; Sood N
    Indian J Lepr; 2003; 75(1):17-24. PubMed ID: 15253391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological shift in leprosy in a rural district of central India following introduction of multi-drug therapy (April 1986 to March 1992 and April 1992 to March 2002).
    Pandey A; Uddin MJ; Patel R
    Lepr Rev; 2005 Jun; 76(2):112-8. PubMed ID: 16038244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Instant" new leprosy case-detection: an experience in Bihar State in India.
    Rao TP; Krishnamurthy P; Vijayakumaran P; Mishra RK; Samy MS
    Indian J Lepr; 2003; 75(1):9-15. PubMed ID: 15253390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leprosy control activities in India: integration into general health system.
    Pandey A; Patel R; Uddin MJ
    Lepr Rev; 2006 Sep; 77(3):210-8. PubMed ID: 17172001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of "cure by dapsone monotherapy' to the reduction of prevalence of leprosy in the State of Orissa, India, 1983-1993.
    Patnaik PK; McDougall AC
    Indian J Lepr; 1996; 68(3):223-6. PubMed ID: 8889607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of leprosy control into general health care system: observations from a state with low endemicity.
    Pandey A; Patel R
    Indian J Lepr; 2005; 77(3):229-38. PubMed ID: 16353521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK; Sharma P
    Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leprosy control in Zambia.
    Steenbergen GJ
    World Health Stat Q; 1991; 44(1):30-5. PubMed ID: 2068823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress towards the elimination of leprosy in Nigeria: a review of the role of policy implementation and operational factors.
    Ogbeiwi OI
    Lepr Rev; 2005 Mar; 76(1):65-76. PubMed ID: 15881037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in epidemiological factors associated with treatment completion status of leprosy patients in the most hyperendemic district of Nepal.
    Kumar RB; Singhasivanon P; Sherchand JB; Mahaisavariya P; Kaewkungwal J; Peerapakorn S; Mahotarn K
    Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):334-9. PubMed ID: 15691132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on risk of leprosy relapses in China: relapses after treatment with multidrug therapy.
    Chen XS; Li WZ; Jiang C; Ye GY
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):379-87. PubMed ID: 10700911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Need and strategy for sentinel surveillance for drug resistance in leprosy in India.
    Joshi PL; Thorat DM; Manglani PR
    Indian J Lepr; 2009; 81(3):113-8. PubMed ID: 20509338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug therapy in leprosy can prevent relapse--a retrospective study.
    Biswas S; Mondal KK
    Indian J Lepr; 2002; 74(4):313-8. PubMed ID: 12624979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in leprosy over fifty years in Gudiyatham Taluk, Vellore, Tamil Nadu.
    Norman G; Raja Samuel Bhushanam JD; Samuel P
    Indian J Lepr; 2006; 78(2):167-85. PubMed ID: 16927851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological trends of leprosy elimination in CLTRI rural field operation area, Tamil Nadu, India.
    Subramanian M; Thorat DM; Krishnan CB; Baig AA; Prabakaran I; Hassan TF; Oommen PK
    Indian J Lepr; 2006; 78(2):203-14. PubMed ID: 16927854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.